Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 6Amaryl
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Diabetes
Currency : USD
2019 Revenue in Millions : 364
2018 Revenue in Millions : 365
Growth (%) : 0
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Diabetes
Currency : USD
2014 Revenue in Millions : -4.00%
2013 Revenue in Millions :
Growth (%) :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Diabetes
Currency : USD
2015 Revenue in Millions : 396
2014 Revenue in Millions : 432
Growth (%) : 9%
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Diabetes
Currency : USD
2016 Revenue in Millions : 384
2015 Revenue in Millions : 417
Growth (%) : -8
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 418
2016 Revenue in Millions : 449
Growth (%) : -7
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Diabetes
Currency : USD
2018 Revenue in Millions : 379
2017 Revenue in Millions : 381
Growth (%) : -1%
LOOKING FOR A SUPPLIER?